Actinium Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Actinium Pharmaceuticals, Inc. (ATNM)

1.325 -0.02 (-1.85%) USD | NYAM | Jan 14, 14:21

View Other Long Term Liabilities (Quarterly) for ATNM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Arcus Biosciences, Inc.	Upgrade
Apyx Medical Corp.	Upgrade
AbbVie, Inc.	Upgrade
Karyopharm Therapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	--